Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Organic Letters
|
April 26, 2003
Acid-promoted Prins cyclizations of enol ethers to form tetrahydropyrans
David J Hart, Chad E Bennett
Pharmaceutics
|
April 26, 2025
Translational Pharmacokinetic-Pharmacodynamic Modeling of a Novel Oral Dihydroorotate Dehydrogenase (DHODH) Inhibitor, HOSU-53 (JBZ-001)
Joo Young Na, Min Hai, Kyeongmin Kim, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 24, 2012
Fused tricyclic mGluR1 antagonists for the treatment of neuropathic pain
Chad E Bennett, Duane A Burnett, William J Greenlee, et al.
Journal of the American Chemical Society
|
November 15, 2002
The practical synthesis of a novel and highly potent analogue of bryostatin
Paul A Wender, Jeremy L Baryza, Chad E Bennett, et al.
Scientific Reports
|
November 3, 2025
OSU-ERβ-12: a promising pre-clinical candidate selective estrogen receptor beta agonist
Gregory M Young, Timothy H Helms, Samuel K Kulp, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 21, 2010
Iminoheterocycles as gamma-secretase modulators
John P Caldwell, Chad E Bennett, Troy M McCracken, et al.
Plos One
|
July 28, 2017
Target specificity, in vivo pharmacokinetics, and efficacy of the putative STAT3 inhibitor LY5 in osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma
Peter Y Yu, Heather L Gardner, Ryan Roberts, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 23, 2012
Synthesis and SAR development of novel mGluR1 antagonists for the treatment of chronic pain
Stephanie Brumfield, Peter Korakas, Lisa S Silverman, et al.
Frontiers in Oncology
|
May 16, 2022
Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer
Jharna Datta, Natalie Willingham, Jasmine M Manouchehri, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 2025
The elucidation of species-specific receptor pharmacology: A case study using subtype-selective para- and meta-carborane estrogen receptor agonists
Adeoluwa A Adeluola, Hanna S Radomska, Tyler A Wilson, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Organic Letters
|
April 26, 2003
Acid-promoted Prins cyclizations of enol ethers to form tetrahydropyrans
David J Hart, Chad E Bennett
Pharmaceutics
|
April 26, 2025
Translational Pharmacokinetic-Pharmacodynamic Modeling of a Novel Oral Dihydroorotate Dehydrogenase (DHODH) Inhibitor, HOSU-53 (JBZ-001)
Joo Young Na, Min Hai, Kyeongmin Kim, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 24, 2012
Fused tricyclic mGluR1 antagonists for the treatment of neuropathic pain
Chad E Bennett, Duane A Burnett, William J Greenlee, et al.
Journal of the American Chemical Society
|
November 15, 2002
The practical synthesis of a novel and highly potent analogue of bryostatin
Paul A Wender, Jeremy L Baryza, Chad E Bennett, et al.
Scientific Reports
|
November 3, 2025
OSU-ERβ-12: a promising pre-clinical candidate selective estrogen receptor beta agonist
Gregory M Young, Timothy H Helms, Samuel K Kulp, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 21, 2010
Iminoheterocycles as gamma-secretase modulators
John P Caldwell, Chad E Bennett, Troy M McCracken, et al.
Plos One
|
July 28, 2017
Target specificity, in vivo pharmacokinetics, and efficacy of the putative STAT3 inhibitor LY5 in osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma
Peter Y Yu, Heather L Gardner, Ryan Roberts, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 23, 2012
Synthesis and SAR development of novel mGluR1 antagonists for the treatment of chronic pain
Stephanie Brumfield, Peter Korakas, Lisa S Silverman, et al.
Frontiers in Oncology
|
May 16, 2022
Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer
Jharna Datta, Natalie Willingham, Jasmine M Manouchehri, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 2025
The elucidation of species-specific receptor pharmacology: A case study using subtype-selective para- and meta-carborane estrogen receptor agonists
Adeoluwa A Adeluola, Hanna S Radomska, Tyler A Wilson, et al.
Page
of 2